Federal Circuit Review | April 2026
Invisible But Invalidating: Undisclosed Functionality Still Triggers On-Sale Bar In Definitive Holdings, LLC v. Powerteq LLC, Appeal No. 24-1761, the Federal Circuit held that a third-party sale of a...
Federal Circuit Review | March 2026
March Federal Circuit Newsletter (Japanese) March Federal Circuit Newsletter (Chinese) Software Claims Failed Alice Step One Where Purported Improvements Were Not Claimed In Trustees Of Columbia University v. Gen Digital...
Federal Circuit Confirms Patent Eligibility of Gene Therapy Patent in Regenexbio Inc. v. Sarepta Therapeutics
Key Takeaway: Genetically engineered cultured host cells containing recombinant nucleic acids useful for gene therapy are patent-eligible for being markedly different from anything occurring in nature. In REGENXBIO Inc. v....